200633-80-3

Applied Filters:

Keyword:'200633-80-3'

Showing 11-20 of 1485 results for "200633-80-3" within Site Content

Protector RNase Inhibitor Protocol

Protector RNase Inhibitor stabilizes RNA at -80°C without permeating intact cells, unsuitable for cell pellet addition.

Merck's Bioprocessing 4.0 Technologies

Blazar™ platform wins R&D 100 and CPhI Awards for reducing testing times by up to 80 percent.

Analysis of Catechins in Green Tea by TLC

TLC-based decaffeinated green tea analysis for epigallocatechin, epicatechin-3-O-gallate, epicatechin, and epigallocatechin-3-O-gallate using TLC Explorer.

Merck Partners with Promega to Advance 3-D Cell Drug Discovery Technologies

Merck and Promega will co-develop novel technologies that advance drug discovery.

Microscopic Examination of Samples

This protocol covers 3 modes for the microscopic examination of cell samples.

Accelerating Protein Degrader Discovery with IAP

Plate of 80 ligands against E3 ligase IAP designed by ComInnex; allows creation of bifunctional targeted protein degraders or molecular glues.

Graphene and New Monoatomic Materials: Using 2-Dimensional Nanosheets in a 3-Dimensional World

Cultrex® 3-D Culture Matrix™ Rat Collagen I Protocol

3-D Culture Matrix™ Collagen I facilitates cellular growth and differentiation in vitro, offering versatile applications in biomedical research.

Dissecting MOCRA Modernization Cosmetic Regulations Act

MoCRA brings the most significant changes to US cosmetic regulations in 80 years, requiring companies to monitor FDA updates and adopt new compliance policies.

What You Need to Know About the New ISO 16140-3 Microbiological Method Verification

This on-demand webinar introduces the new EN ISO 16140-3 on the verification of methods in food microbiology.

Page 2 of 149